132 related articles for article (PubMed ID: 7678826)
1. Sustained recovery of Na(+)-K(+)-ATPase activity in sciatic nerve of diabetic mice by administration of H7 or calphostin C, inhibitors of PKC.
Hermenegildo C; Felipo V; Miñana MD; Romero FJ; Grisolía S
Diabetes; 1993 Feb; 42(2):257-62. PubMed ID: 7678826
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of protein kinase C restores Na+,K(+)-ATPase activity in sciatic nerve of diabetic mice.
Hermenegildo C; Felipo V; Miñana MD; Grisolía S
J Neurochem; 1992 Apr; 58(4):1246-9. PubMed ID: 1312572
[TBL] [Abstract][Full Text] [Related]
3. Prevention of the acute neurotoxic effects of phenytoin on rat peripheral nerve by H7, an inhibitor of protein kinase C.
Raya A; Gallego J; Hermenegildo C; Puertas FJ; Romero FJ; Felipo V; Miñana MD; Grisolía S; Romá J
Toxicology; 1992 Nov; 75(3):249-56. PubMed ID: 1333652
[TBL] [Abstract][Full Text] [Related]
4. Cyclic adenosine 3',5'-monophosphate enhances sodium, potassium-adenosine triphosphatase activity in the sciatic nerve of streptozotocin-induced diabetic rats.
Shindo H; Tawata M; Onaya T
Endocrinology; 1993 Feb; 132(2):510-6. PubMed ID: 7678791
[TBL] [Abstract][Full Text] [Related]
5. Normalization of Na(+)-K(+)-ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro.
Kim J; Kyriazi H; Greene DA
Diabetes; 1991 May; 40(5):558-67. PubMed ID: 1850704
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of retinal metabolism in diabetes or experimental galactosemia: V. Relationship between protein kinase C and ATPases.
Kowluru RA; Jirousek MR; Stramm L; Farid N; Engerman RL; Kern TS
Diabetes; 1998 Mar; 47(3):464-9. PubMed ID: 9519755
[TBL] [Abstract][Full Text] [Related]
7. In vivo phosphorylation of the Na,K-ATPase alpha subunit in sciatic nerves of control and diabetic rats: effects of protein kinase modulators.
Borghini I; Geering K; Gjinovci A; Wollheim CB; Pralong WF
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6211-5. PubMed ID: 8016140
[TBL] [Abstract][Full Text] [Related]
8. In vitro correction of impaired Na+-K+-ATPase in diabetic nerve by protein kinase C agonists.
Lattimer SA; Sima AA; Greene DA
Am J Physiol; 1989 Feb; 256(2 Pt 1):E264-9. PubMed ID: 2537578
[TBL] [Abstract][Full Text] [Related]
9. ATPase activity defects in alloxan-induced diabetic sciatic nerve recovered by ganglioside treatment.
Bianchi R; Marini P; Merlini S; Fabris M; Triban C; Mussini E; Fiori MG
Diabetes; 1988 Oct; 37(10):1340-5. PubMed ID: 2843406
[TBL] [Abstract][Full Text] [Related]
10. Effect of experimental diabetes on Na/K-ATPase activity in red blood cells, peripheral nerve and kidney.
Raccah D; Lamotte-Jannot MF; Issautier T; Vague P
Diabete Metab; 1994; 20(3):271-4. PubMed ID: 8001715
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle.
Shimamoto Y; Shimamoto H; Kwan CY; Daniel EE
Am J Physiol; 1993 Apr; 264(4 Pt 2):H1300-6. PubMed ID: 7682791
[TBL] [Abstract][Full Text] [Related]
12. Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved.
Martínez-Blasco A; Bosch-Morell F; Trenor C; Romero FJ
Biofactors; 1998; 8(1-2):41-3. PubMed ID: 9699007
[TBL] [Abstract][Full Text] [Related]
13. The protein kinase C inhibitor, calphostin C, inhibits succinate-dependent mitochondrial reduction of MTT by a mechanism that does not involve protein kinase C.
Berridge MV; Tan AS
Biochem Biophys Res Commun; 1992 Jun; 185(3):806-11. PubMed ID: 1378266
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of the protein kinase C inhibitors H7 and calphostin C on the cell cycle of neuroblastoma cells.
Miñana MD; Felipo V; Grisolía S
Brain Res; 1992 Nov; 596(1-2):157-62. PubMed ID: 1281743
[TBL] [Abstract][Full Text] [Related]
15. Diminished specific activity of cytosolic protein kinase C in sciatic nerve of streptozocin-induced diabetic rats and its correction by dietary myo-inositol.
Kim J; Rushovich EH; Thomas TP; Ueda T; Agranoff BW; Greene DA
Diabetes; 1991 Nov; 40(11):1545-54. PubMed ID: 1657670
[TBL] [Abstract][Full Text] [Related]
16. Induction of apoptotic DNA fragmentation and cell death in HL-60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C.
Jarvis WD; Turner AJ; Povirk LF; Traylor RS; Grant S
Cancer Res; 1994 Apr; 54(7):1707-14. PubMed ID: 7511048
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of protein kinase C prevent the toxicity of glutamate in primary neuronal cultures.
Felipo V; Miñana MD; Grisolía S
Brain Res; 1993 Feb; 604(1-2):192-6. PubMed ID: 7681344
[TBL] [Abstract][Full Text] [Related]
18. Cholinergic inhibition of Na-K-ATPase via activation of protein kinase C in Madin-Darby canine kidney cells.
Garg LC; Saha PK; Mohuczy-Dominiak D
J Am Soc Nephrol; 1993 Aug; 4(2):195-205. PubMed ID: 8400083
[TBL] [Abstract][Full Text] [Related]
19. Suppression of cytochrome P450 Cyp1a-1 induction in murine hepatoma 1c1c7 cells by 12-O-tetradecanoylphorbol-13-acetate and inhibitors of protein kinase C.
Reiners JJ; Schöller A; Bischer P; Cantu AR; Pavone A
Arch Biochem Biophys; 1993 Mar; 301(2):449-54. PubMed ID: 7681664
[TBL] [Abstract][Full Text] [Related]
20. Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters.
Djemli-Shipkolye A; Coste T; Raccah D; Vague P; Pieroni G; Gerbi A
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):297-304. PubMed ID: 11355004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
